{"accession":"0001549595-26-000049","article_url":"https://aiswingx.com/p/nrix-2026q3","attribution":"aiSwingX \u2014 https://aiswingx.com/n/0001549595-26-000049/IncomeTaxExpenseBenefit","change":null,"cik":1549595,"company":"NURIX THERAPEUTICS, INC.","concept":{"label":"Income tax","label_en":"Income tax","label_ko":"\ubc95\uc778\uc138","period_type":"duration","xbrl_tag":"IncomeTaxExpenseBenefit"},"filed_at":"2026-10-13","filing_index_url":"https://www.sec.gov/Archives/edgar/data/1549595/000154959526000049/0001549595-26-000049-index.htm","filing_url":"https://aiswingx.com/f/0001549595-26-000049","form":"10-Q","id":"0001549595-26-000049/IncomeTaxExpenseBenefit","license":"https://aiswingx.com/terms","observations":[{"instant":false,"period_end":"2026-08-31","period_start":"2026-06-01","source_url":"https://www.sec.gov/Archives/edgar/data/1549595/000154959526000049/nrix-20260831.htm#f-141","unit":"USD","value":13606000.0,"xbrl_fact_id":"f-141"},{"comparative":true,"instant":false,"period_end":"2025-08-31","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/1549595/000154959526000049/nrix-20260831.htm#f-142","unit":"USD","value":0.0,"xbrl_fact_id":"f-142"}],"statement":"NURIX THERAPEUTICS, INC. (NRIX) reported Income tax of USD 13,606,000 for the period from 2026-06-01 to 2026-08-31 in its 10-Q (accession 0001549595-26-000049, filed 2026-10-13).","ticker":"NRIX","url":"https://aiswingx.com/n/0001549595-26-000049/IncomeTaxExpenseBenefit","verify_url":"https://www.sec.gov/Archives/edgar/data/1549595/000154959526000049/nrix-20260831.htm#f-141"}